Mode
Text Size
Log in / Sign up
N/A N=70 Randomized Double-blind Treatment

Hysterectomy by Transabdominal Laparoscopy or NOTES

Uterine Diseases

Enrolled (actual)
70
Serious AEs
2.9%
Results posted
Jun 2020
Primary outcome: Primary: Successful Removal of the Uterus Without Conversion to Another Technique — 35; 35 Participants — p=0.0221

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
vNOTES hysterectomy (Procedure); LSC hysterectomy (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Imelda Hospital, Bonheiden
Primary completion
Feb 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Successful Removal of the Uterus Without Conversion to Another Technique
35; 35 0.0221 sig
SECONDARY
Admission in Hospital for at Least One Night Observation
8; 20 0.007 sig
SECONDARY
Postoperative Pain Scores
3.629; 4.200; 3.486; 4.456; 2.486; 3.543
SECONDARY
The Use of Analgetic Drugs for Postoperative Pain
8.0; 13.9 0.006 sig
SECONDARY
Postoperative Infection
1; 2 1.00
SECONDARY
Intra- Operative Complications
1; 0 > 0.05
SECONDARY
Postoperative Complications
3; 13 0.009 sig
SECONDARY
Hospital Readmission
1; 6 0.106
SECONDARY
Duration of the Surgical Intervention
41.1; 75.1 < 0.01 sig
SECONDARY
Vaginal Pain During Sexual Intercourse at Three Months
8; 9 0.7604
SECONDARY
Vaginal Pain During Sexual Intercourse at Six Months
5; 8 0.3071
SECONDARY
Pelvic Pain During Sexual Intercourse at Three Months
6; 8 0.4541
SECONDARY
Pelvic Pain During Sexual Intercourse at Six Months
4; 5 0.4514
SECONDARY
Health-related Quality of Life at Three Months
83.8; 79.6 0.3473
SECONDARY
Health-related Quality of Life at Six Months
87.8; 86.6 0.3473
SECONDARY
Sexual Well Being
SECONDARY
Direct Costs
3452.2; 3933.6 0.110

Summary

Objective: To randomly compare hysterectomy by vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) versus laparoscopy uterus in women with benign gynecological pathology. Study design: Randomized controlled/single center/single-blinded/parallel-group/non-inferiority/efficacy trial. Study population: All women aged 18 to 70 years regardless of parity with a non-prolapsed uterus and a benign indication for hysterectomy. Primary study outcome parameters: successful removal of the uterus by the intended technique. Secondary outcomes: the proportion of women admitted to the in-hospital ward; postoperative pain scores; the total amount of analgesics used; postoperative infection; per- or postoperative complications; hospital readmission rates; duration of the surgical procedure; incidence and intensity of dyspareunia; sexual wellbeing; health-related quality of life; costs.

Eligibility Criteria

Inclusion Criteria

  • All women aged 18 to 70 years regardless of parity, with a non-prolapsed uterus in need of a hysterectomy for benign indication
  • Written informed consent obtained prior to surgery

Exclusion Criteria

  • History of rectal surgery
  • Suspected rectovaginal endometriosis
  • Suspected malignancy
  • History of pelvic inflammatory disease, especially prior tubo-ovarian or pouch of Douglas abscess
  • Active lower genital tract infection e.g. Chlamydia, N. gonorrhoeae
  • Virgo
  • Pregnancy
  • Failure to provide written informed consent prior to surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02631837). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search